Literature DB >> 27783578

Pathology: The prion principle.

Simon Makin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27783578     DOI： 10.1038/538S13a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

1.  Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.

Authors:  Jeffrey H Kordower; Yaping Chu; Robert A Hauser; Thomas B Freeman; C Warren Olanow
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

2.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

3.  Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.

Authors:  Kelvin C Luk; Victoria Kehm; Jenna Carroll; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

4.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  Identification of a protein that purifies with the scrapie prion.

Authors:  D C Bolton; M P McKinley; S B Prusiner
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

6.  Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.

Authors:  Marta Martinez-Vicente; Zsolt Talloczy; Susmita Kaushik; Ashish C Massey; Joseph Mazzulli; Eugene V Mosharov; Roberto Hodara; Ross Fredenburg; Du-Chu Wu; Antonia Follenzi; William Dauer; Serge Przedborski; Harry Ischiropoulos; Peter T Lansbury; David Sulzer; Ana Maria Cuervo
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

7.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Authors:  Jia-Yi Li; Elisabet Englund; Janice L Holton; Denis Soulet; Peter Hagell; Andrew J Lees; Tammaryn Lashley; Niall P Quinn; Stig Rehncrona; Anders Björklund; Håkan Widner; Tamas Revesz; Olle Lindvall; Patrik Brundin
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

8.  Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.

Authors:  Ariadna Recasens; Benjamin Dehay; Jordi Bové; Iria Carballo-Carbajal; Sandra Dovero; Ana Pérez-Villalba; Pierre-Olivier Fernagut; Javier Blesa; Annabelle Parent; Celine Perier; Isabel Fariñas; José A Obeso; Erwan Bezard; Miquel Vila
Journal:  Ann Neurol       Date:  2014-02-18       Impact factor: 10.422

9.  MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration.

Authors:  Carolina Cebrián; Fabio A Zucca; Pierluigi Mauri; Julius A Steinbeck; Lorenz Studer; Clemens R Scherzer; Ellen Kanter; Sadna Budhu; Jonathan Mandelbaum; Jean P Vonsattel; Luigi Zecca; John D Loike; David Sulzer
Journal:  Nat Commun       Date:  2014-04-16       Impact factor: 14.919

10.  Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease.

Authors:  Nolwen L Rey; Jennifer A Steiner; Nazia Maroof; Kelvin C Luk; Zachary Madaj; John Q Trojanowski; Virginia M-Y Lee; Patrik Brundin
Journal:  J Exp Med       Date:  2016-08-08       Impact factor: 14.307
View more
  12 in total

1.  Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo.

Authors:  Su Peng; Caiping Wang; Jinyu Ma; Ketao Jiang; Yuhui Jiang; Xiaosong Gu; Cheng Sun
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

2.  PrP P102L and Nearby Lysine Mutations Promote Spontaneous In Vitro Formation of Transmissible Prions.

Authors:  Allison Kraus; Gregory J Raymond; Brent Race; Katrina J Campbell; Andrew G Hughson; Kelsie J Anson; Lynne D Raymond; Byron Caughey
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

3.  Brain Delivery of Curcumin Through Low-Intensity Ultrasound-Induced Blood-Brain Barrier Opening via Lipid-PLGA Nanobubbles.

Authors:  Yiran Yan; Yan Chen; Zhongxun Liu; Feiyan Cai; Wanting Niu; Liming Song; Haifeng Liang; Zhiwen Su; Bo Yu; Fei Yan
Journal:  Int J Nanomedicine       Date:  2021-11-04

Review 4.  Initiation and Transmission of α-Synuclein Pathology in Parkinson's Disease.

Authors:  Alex Mazurskyy; Jason Howitt
Journal:  Neurochem Res       Date:  2019-11-11       Impact factor: 3.996

5.  Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified.

Authors:  Bjørn Grinde; Bo Engdahl
Journal:  Immun Ageing       Date:  2017-08-31       Impact factor: 6.400

Review 6.  Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

Review 7.  The human olfactory system in two proteinopathies: Alzheimer's and Parkinson's diseases.

Authors:  Isabel Ubeda-Bañon; Daniel Saiz-Sanchez; Alicia Flores-Cuadrado; Ernesto Rioja-Corroto; Melania Gonzalez-Rodriguez; Sandra Villar-Conde; Veronica Astillero-Lopez; Juan Pablo Cabello-de la Rosa; Maria Jose Gallardo-Alcañiz; Julia Vaamonde-Gamo; Fernanda Relea-Calatayud; Lucia Gonzalez-Lopez; Alicia Mohedano-Moriano; Alberto Rabano; Alino Martinez-Marcos
Journal:  Transl Neurodegener       Date:  2020-06-03       Impact factor: 8.014

8.  Targeted exosome coating gene-chem nanocomplex as "nanoscavenger" for clearing α-synuclein and immune activation of Parkinson's disease.

Authors:  Linying Liu; Yan Li; Huan Peng; Ruiyuan Liu; Weihong Ji; Zhuyan Shi; Jie Shen; Guanghui Ma; Xin Zhang
Journal:  Sci Adv       Date:  2020-12-11       Impact factor: 14.136

9.  Linking Stage-Specific Plasma Biomarkers to Gray Matter Atrophy in Parkinson Disease.

Authors:  W-C Lin; P-L Lee; C-H Lu; C-P Lin; K-H Chou
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-27       Impact factor: 4.966

10.  Exceptional in vivo catabolism of neurodegeneration-related aggregates.

Authors:  Zsolt Datki; Zita Olah; Tibor Hortobagyi; Lilla Macsai; Katalin Zsuga; Livia Fulop; Zsolt Bozso; Bence Galik; Eva Acs; Angela Foldi; Amanda Szarvas; Janos Kalman
Journal:  Acta Neuropathol Commun       Date:  2018-01-29       Impact factor: 7.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.